Grantham, Mayo, Van Otterloo & Co (GMO)’s Vulcan Materials VMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
19,377
-2,668
-12% -$765K 0.01% 315
2026
Q1
$6M Buy
22,045
+2,197
+11% +$646K 0.02% 293
2025
Q4
$5.66M Buy
+19,848
New +$5.82M 0.01% 294
2025
Q1
Sell
-10,289
Closed -$2.65M 673
2024
Q4
$2.65M Buy
+10,289
New +$2.77M 0.01% 353
2023
Q4
Sell
-5,685
Closed -$1.15M 586
2023
Q3
$1.15M Buy
+5,685
New +$1.24M 0.01% 443
2021
Q3
Sell
-12,000
Closed -$2.09M 773
2021
Q2
$2.09M Buy
+12,000
New +$2.15M 0.01% 458
2014
Q1
Sell
-70,000
Closed -$4.16M 641
2013
Q4
$4.16M Hold
70,000
0.01% 340
2013
Q3
$3.63M Hold
70,000
0.01% 351
2013
Q2
$3.39M Buy
+70,000
New +$3.59M 0.01% 353

Other funds holding VMC

Grantham, Mayo, Van Otterloo & Co (GMO)'s VMC Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Vulcan Materials (VMC) stake by 12% in Q2 2026, selling an estimated $765K and leaving 19,377 shares worth $5.72M. The position accounts for 0.01% of the portfolio, ranked #315.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VMC in Q2 2013 and has held it in 9 quarters since. The position peaked at $6M in Q1 2026. 1,065 funds tracked by Wall St. Rank hold VMC as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 19,377 shares of Vulcan Materials worth $5.72M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,668 Vulcan Materials shares in Q2 2026, an estimated $765K.
  • Vulcan Materials made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #315 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Vulcan Materials in Q2 2013 and has held it in 9 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Vulcan Materials position peaked at $6M in Q1 2026.
  • 1,065 funds tracked by Wall St. Rank held Vulcan Materials as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.